Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from ADMA Biologics ( (ADMA) ).
ADMA Biologics, Inc. has reassured analysts that the recent change in auditors, detailed in their latest report, will not affect the financial projections for the years 2024-2025. The company’s management confirmed that the transition of auditors is expected to proceed without impacting their previously stated financial guidance.
See more data about ADMA stock on TipRanks’ Stock Analysis page.
